DeepIntent Unveils DeepIntent Cortex™, Ushering in the Next Generation of Healthcare Demand Side Platforms

NEW YORK, March 25, 2025 /PRNewswire/ -- DeepIntent, the leading healthcare advertising technology company, today introduced DeepIntent Cortex, its most advanced demand side platform (DSP) upgrade to date. Inspired by the human brain's ability to process complex information, DeepIntent Cortex seamlessly integrates artificial intelligence (AI) with real-time media buying and daily-refreshed health data, delivering an intuitive, Health Intelligent™ media buying experience that elevates speed, choice, precision, and scale like never before.

The result of nearly two years of product development, DeepIntent Cortex meets the industry's growing demand for more personalized ad experiences by connecting marketing performance to real-world health outcomes at every stage of a campaign. With streamlined workflows and secure access to health data, Cortex leverages AI-powered Health Intelligence to enhance efficiency across digital channels and deliver actionable health and media insights that drive more strategic media investments.

"DeepIntent Cortex gives healthcare marketers a decisive edge by seamlessly connecting campaign performance with real-world health outcomes," said Chris Paquette, Founder and CEO of DeepIntent. "By accelerating access to critical data and insights, Cortex sets a new standard for data-driven marketing by empowering marketers with advanced tools, AI-driven Health Intelligence, and access to our industry's most premium data and media. With enhanced speed, precision, and scale, brands can optimize performance, adapt with agility, and drive superior results in an increasingly competitive market."

Key Enhancements of DeepIntent Cortex

A Streamlined UX Built for Speed, Insight, and Action

Built for and with programmatic traders in healthcare, Cortex accelerates campaign management by uniting health and media insights into a seamless workflow. AI-driven automation reduces campaign management and optimization time by up to 50%, enabling faster decision-making and execution.

Unparalleled Access to Premium Health Data

Backed by significant investment in a privacy-centric data infrastructure, Cortex offers direct access to a premium marketplace of health and media data. Clients can explore insights and select their preferred health data provider to power all aspects of their campaign, including campaign planning and optimization.

Precise Health Intelligent Optimization

DeepIntent's patented real-time DeepIntent Outcomes™ optimization uses real-world clinical and media data to optimize bidding, ensuring ad spend is directed toward high-impact impressions that drive script lift and improve patient outcomes.

DeepIntent Cortex enhances this methodology, delivering a 25% improvement—raising the average audience quality (AQ) lift by 80% in initial testing. Additionally, it introduces Predictive AQ Optimization, empowering traders to visualize the impact of AQ optimization before buying media. This innovation maximizes working media investment through AI-supported decision-making that can lead to better outcomes and more relevant patient engagement.

Scaled Audience Access with HealthFirst™ Packages

In healthcare advertising, scale is only valuable when it is relevant. Cortex delivers this with new HealthFirst™ Packages, curated marketplaces that provide seamless access to premium endemic inventory and connected TV (CTV) placements. By leveraging strategic publisher partnerships, these packages—enhanced by Health Intelligent targeting and optimization—ensure advertisers reach high-value healthcare audiences with precision and impact.

Enhanced Healthcare Provider (HCP) Capabilities

Cortex elevates HCP media strategy with end-to-end enhancements, including advanced tools for audience analytics and insights, in-platform AI-driven recommendations for campaign optimization, and a new NPI-based site analytics dashboard integrated into DeepIntent Outcomes™ for a comprehensive view of HCP engagement.

"After nearly two years of development, DeepIntent Cortex is a true breakthrough—bringing seamless, data-driven media buying to the healthcare industry," said Aaron Fulmer, SVP of Product at DeepIntent. "By integrating health and media insights into every stage of the buying process, Cortex not only saves traders valuable time but also ensures smarter, more effective campaign execution. It marks a major step forward for digital healthcare advertising."

Unveiling DeepIntent Cortex at AdLab

DeepIntent is unveiling Cortex today at its AdLab event in New York City, featuring a distinguished lineup of industry leaders, including Chris Paquette, Founder and CEO of DeepIntent; Melissa Gordon-Ring, Global President of IPG Mediabrands Health; Matt McNally, Global CEO of Publicis Health; Kevin Kammeyer, Director of Media Strategy & Operations at Gilead; Erin Nocito, Executive Director, Head of Global Media at Amgen; and other key voices shaping the future of health advertising.

Learn more about DeepIntent Cortex here.

About DeepIntent

DeepIntent is the health advertising platform marketers trust to drive effective campaigns. Purpose-built for healthcare and privacy-safe, the DeepIntent platform unites media and clinical data to produce industry-defining Health Intelligence. Consistently proven to deliver real-world results through real-time optimization, the DeepIntent platform powers more than 600 pharmaceutical brands and all the leading healthcare agencies—enabling them to innovate, differentiate, and reach their audiences across all channels and devices.

For more information, visit DeepIntent.com or follow us on LinkedIn.

 Media Contact
[email protected] 

SOURCE DeepIntent